Human Vaccine Adjuvants Market Scope And Analysis

Human Vaccine Adjuvants Market Report Scope

Human Vaccine Adjuvants Market News and Recent Developments

The Human vaccine adjuvants market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Human vaccine adjuvants market are listed below:

• SPI Pharma Inc collaborated with Q-Vant Biosciences Inc this partnership combines Q-Vant's technology with SPI global reach and services. The arrangement includes investment in the expansion of Q-Vant’s proprietary 100% sustainable Q-SAP technology and an exclusive commercial agreement to accelerate the global adoption of their saponin adjuvants for veterinary and human vaccine formulations. (Source: SPI Pharma, Newsletter, October 2023)
• Croda International Plc partnered with Amyris and Botanical Solutions Inc (BSI) for for the supply of biotechnology-derived, pharmaceutical grade squalene used in adjuvants to boost immune responses and to produce a sustainable pharmaceutical grade QS-21 vaccine adjuvant which enable the production of next generation adjuvant systems for new vaccine development respectively. (Source: Croda International Plc, Newsletter, May 2023)
• The Defense Threat Reduction Agency's (DTRA) Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense (CBD) Program has awarded, through the Medical CBRN [Chemical, Biological, Radiological, and Nuclear] Defense Consortium (MCDC) requirement 22-05, "Adjuvant Activity to Vaccines Prototype," a 5-year contract totaling up to $31 million including program options to the team of Ginkgo Bioworks, Inc. and SaponiQx, Inc. to discover and develop next-generation vaccine adjuvants. This will require to use a combination of high-throughput empirical and artificial intelligence/machine learning approaches, including Generative Molecular Design (GMD), to develop superior novel saponin-based adjuvants.( Ginkgo Bioworks, Inc., Press Release, February 2024)

Human Vaccine Adjuvants Market Report Coverage and Deliverables

The “Human Vaccine Adjuvants Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

• Human vaccine adjuvants market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Human vaccine adjuvants market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Human vaccine adjuvants market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Human vaccine adjuvants market
• Detailed company profiles